HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (...

FDA Drug Recall #D-1239-2015 — Class III — June 29, 2015

Recall Summary

Recall Number D-1239-2015
Classification Class III — Low risk
Date Initiated June 29, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Qualitest Pharmaceuticals
Location Huntsville, AL
Product Type Drugs
Quantity 47,376 bottles

Product Description

HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL

Reason for Recall

Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable

Distribution Pattern

Nationwide

Lot / Code Information

100 count (NDC 0603-3968-21); LOTS# T144F13A, T130G13B, T132G13A, exp date 6/15, T115D14A, exp date 3/16; 500 count (NDC 0603-3968-28), LOT# T144F13B exp date 6/15; and 1000 count (NDC 0603-3968-32); LOTS # T144F13C, T132G13B, exp date 6/15, T115D14B, exp date 3/16

Other Recalls from Qualitest Pharmaceuticals

Recall # Classification Product Date
D-1405-2015 Class III ALLOPURINOL TABLETS, USP, 300 mg, 500 count bot... Jul 20, 2015
D1151-2015 Class III Disulfiram tablets, USP, 500 mg, 100-count bott... Jun 18, 2015
D00432-2015 Class III PROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml c... Mar 25, 2015
D-0411-2015 Class II PROMETHAZINE DM SYRUP (Promethazine Hydrochlori... Feb 23, 2015
D-0397-2015 Class II AMLODIPINE BESYLATE TABLETS USP, 10 mg*, 1000 c... Feb 13, 2015

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.